Reuters logo
BRIEF-Intellia therapeutics announces European Patent Office's decision
2017年4月11日 / 中午11点52分 / 7 个月前

BRIEF-Intellia therapeutics announces European Patent Office's decision

April 11 (Reuters) - Intellia Therapeutics Inc

* Intellia Therapeutics announces European Patent Office’s decision to grant crispr/cas9 genome editing technology patent

* Intellia Therapeutics - patent covers compositions of crispr single guide RNA technology for use in non-cellular, cellular settings, including eukaryotic cells

* Intellia Therapeutics - EPO’s decision to grant patent follows its March 24, notice of intent to issue patent, which was not challenged by any third party

* Intellia Therapeutics - European patent will cover, approximately forty European countries, including Germany, Italy, France, Spain and Netherlands Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below